References
- Office of Health Economics. Compendium of health statistics12th edition. Office of Health Economics, London 2000
- The National Institute for Healthcare Management Research and Educational Foundation. Prescription drug expenditures in 2000: the upward trend continues. NIHCM Foundation, Washington, DC 2001
- Martin JP. Social aspects of prescribing. William Heinemann Ltd, London 1957
- Mossialos E, Abel-Smith B. Cost-containment in the pharmaceutical sector in the EU member states. London School of Economics, London 1996
- Ferriman A. Report suggests that NHS is unsustainable in present form. BMJ 1999; 319: 801
- Dowell J S, Snadden D, Dunbar JA. Changing to generic formulary: how one fundholding practice reduced prescribing costs. BMJ 1995; 310: 505–8
- Anon. Harmful effects of practice budgets. BMJ 1989; 298: 1316
- Smith L FP, Morrissy JR. Ethical dilemmas for general practitioners under the UK new contract. J Med Ethics 1994; 20: 175–80
- Avery A J, Rodgers S, Heron T, Crombie R, Whynes D, Pringle M, et al. A prescription for improvement? An observational study to identify how general practices vary in their growth in prescribing costs. BMJ 2000; 321: 276–81
- Schoffski O. Consequences of implementing a drug budget for office-based physicians in Germany. Pharmacoeconomics 1996; 10: S37–47, Suppl. 2
- Reebye R N, Avery A J, van den Bosch W JHM, Aslam M, Nijholt A, van der Bij A. Exploring community pharmacists' perceptions of their professional relationships with physicians in Canada and the Netherlands. Int J Pharm Pract 1999; 7: 149–58
- Lambert L. Face and politeness in pharmacist-physician interaction. Soc Sci Med 1996; 8: 1189–98